Key facts
- Notable investors include Keio Innovation Initiative, 1stRound, ATTD- Advanced Technologies & Treatments for Diabetes, IT-Farm, Nineteen Twenty-One.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for T1D Scout
- ·The full record, as it builds
Funding rounds
No funding rounds for T1D Scout are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About T1D Scout
Developer of an online Type 1 diabetes (T1D) screening platform designed to make T1D risk detection accessible from home. The company's platform offers at-home saliva-based DNA tests, at-home autoantibody follow-up tests, and online counseling, enabling individuals and families concerned about T1D to access early risk detection and personalized support while maintaining data privacy.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Employees
- 4
- Website
- t1dscout.com/
- Ownership
- Privately Held (backing)
T1D Scout doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in T1D Scout shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on T1D Scout in its N-PORT filings yet. We sweep new filings monthly.